New research on intravenous drugs for TBI
Every year, many people in Louisiana are affected by traumatic brain injuries. A person who is injured in a serious car accident may sustain a traumatic brain injury that leaves them unconscious or paralyzed while an athlete playing contact sports might experience a mild concussion with symptoms like dizziness.
Researchers at the Sanford Burnham Prebys Medical Discovery Institute believe that they have discovered a new way to help the 2.5 million people affected by traumatic brain injuries every year in the United States. Though the initial TBI cannot be repaired in an injured patient, researchers may have found a way to minimize the injury’s subsequent damaging effects.
Other studies have already identified over 100 compounds that can decrease the degree of brain damage that a person experiences after suffering from a TBI. However, the compounds must be injected directly into a patient’s brain, a highly invasive procedure that can lead to complications. The new research is looking at a new technique for administering drugs intravenously. Researchers say that they have found a peptide sequence that can recognize brain tissue. The peptide sequence may be used to deliver treatments to the brain after a TBI and could help to reduce intracranial pressure and maintain blood flow.
A traumatic brain injury can lead to permanent brain damage that can have a significant impact on a person’s life. Many people with brain injuries are unable to continue working in their former occupations. A lawyer might be able to help a person who has lost their livelihood because of a TBI pursue monetary compensation from liable parties.
Tags: Brain Injuries